Lymphoid neoplasms were significantly enriched for deletions in genes of the following pathways: p53 (18% vs 5%, q (FDR-corrected p-value) =1.15 × 10–15, two-proportion Z-test), immune modulation (11% vs 0%, q = 9.25 × 10–18), NOTCH signaling (10% vs 2%, q = 1.47 × 10−10), chromatin modifiers (9% vs 5%, q = 4.18 × 10−2), DNA damage response (7% vs 0%, q = 9.51 × 10–12), and NF-kB signaling (6% vs 1%, q = 2.26 × 10−7). This evidence concerns the gene TP53 and lymphoid neoplasm.